| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00101907 Details | 2014-03-20 Interventional | 1 | 41 | Gemcitabine Motesanib dipho… Panitumumab Esophageal Canc… Lung Cancer Pancreatic Canc… | Study terminated per recommendation of Data Review Team - | |||
| NCT00866034 Details | 2014-03-19 Interventional | 4 | 617 | Cetrorelix In Vitro Fertil… Intracytoplasmi… | Due to limited rate of patient inclusion The study was terminated prematurely because no significant difference was observed in clinical outcome after 617 inclusions. A much larger population would be needed to detect a small significant difference in favour of either study arm. | |||
| NCT00353574 Details | 2014-03-18 Interventional | 3 | 282 | Darusentan Hypertension | Study DAR-312 did not meet primary co-endpoints - | |||
| NCT01451723 Details | 2014-03-14 Interventional | 2 | 11 | Epigallocatechi… Multiple Sclero… Sclerosis | Unusual high frequency of elevated liver function tests. The study was halted prematurely because of the high incidence of liver function abnormalities | |||
| NCT00396383 Details | 2014-03-13 Interventional | 2 | [2 Refs] | 9 | Plerixafor Multiple Myelom… Neoplasms, Plas… | Insufficient cell mobilization for tandem transplants Study had limited enrollment prior to termination. | ||
| NCT00285493 Details | 2014-03-13 Interventional | 1 | 0 | Anti-Bacterial … Back Pain Low Back Pain | Withdrawn: study halted prematurely, prior to enrollment of first participant - | |||
| NCT00112164 Details | 2014-03-13 Interventional | 2 | - | Drotrecogin alf… Acute Lung Inju… Lung Injury Respiratory Dis… Respiratory Dis… Respiratory Dis… | Per recommendation of the NHLBI DSMB - | |||
| NCT01641575 Details | 2014-03-11 Interventional | 1 | 8 | Gemcitabine Carcinoma, Non-… Lung Neoplasms Lung Cancer Non-small-cell … Solid Tumor | Registrational study did not meet endpoint so entire program (including CO-101-011) was
terminated. - | |||
| NCT00369551 Details | 2014-03-06 Interventional | 1 | 36 | Antibodies Antibodies, Mon… Antineoplastic … Bevacizumab Carboplatin Immunoglobulins Paclitaxel Adenocarcinoma … Adenocarcinoma,… Carcinoma, Non-… Lung Neoplasms Adenocarcinoma … Bronchoalveolar… Large Cell Lung… Stage II Non-sm… Stage IIIA Non-… Stage IIIB Non-… | - - | |||
| NCT01556334 Details | 2014-03-05 Interventional | 3 | 0 | Azithromycin Erythromycin Erythromycin Es… Erythromycin Et… Erythromycin st… Fetal Membranes… Premature Birth Rupture Preterm Prematu… | Terminated before starting due to need for IND determined by FDA. - | |||
| NCT01131559 Details | 2014-03-05 Interventional | 3 | - | Lisdexamfetamin… Bipolar Disorde… Depression Depressive Diso… Bipolar | Sponsor halted study. - | |||
| NCT01033149 Details | 2014-03-05 Interventional | 3 | [1 Refs] | 11 | Acetylcysteine N-monoacetylcys… Bulimia Bulimia Nervosa | - - | ||
| NCT00742313 Details | 2014-03-05 Interventional | 4 | 50 | Hemostatics Hemorrhage Bleeding | No statistical differences on study endpoints between groups. This study was terminated early | |||
| NCT01776320 Details | 2014-03-04 Interventional | 4 | 0 | Alprostadil Erectile Dysfun… | No medication - | |||
| NCT01522196 Details | 2014-03-04 Interventional | 2 | 2 | Varespladib met… Anemia, Sickle … Sickle Cell Dis… Vaso-occlusive … | change in company plans - | |||
| NCT01079767 2009-014443-36 Details | 2014-03-04 Interventional | 2 | 6 | MTOR Inhibitors Sirolimus Temsirolimus Liver Neoplasms Liver Cancer | The study treminated early according to DSMB recommendantions - | |||
| NCT00522834 Details | 2014-03-04 Interventional | 3 | 630 | Paclitaxel Melanoma | - - | |||
| NCT00666393 Details | 2014-03-03 Interventional | 3 | 0 | Fentanyl Pain, Postopera… Pediatrics | Program Cancelled. - | |||
| NCT01699854 2012-001540-22 Details | 2014-02-26 Interventional | 3 | - | Capsaicin Persistent Pain… | Expiration of the placebo patch - | |||
| NCT00887640 Details | 2014-02-26 Interventional | 2 | 11 | Diphenhydramine MTOR Inhibitors Promethazine Sirolimus Temsirolimus Neoplastic Cell… Prostatic Neopl… Prostate Cancer | - - |